Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

From Cuff Arthropathy to Reverse Shoulder Arthroplasty - a Multicentre Randomized Control Trial (Study 1: Does BIO-RSA Provides Superior Clinical Outcome Compared to Conventional RSA?).

NCT06025331 is registered in ClinicalTrials.gov with Lovisenberg Diakonale Hospital as lead sponsor.

NCT NCT06025331
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT06025331 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
From Cuff Arthropathy to Reverse Shoulder Arthroplasty - a Multicentre Randomized Control Trial (Study 1: Does BIO-RSA Provides Superior Clinical Outcome Compared to Conventional RSA?).
Lead sponsor
Lovisenberg Diakonale Hospital
Phase
Not applicable
Overall status
Recruiting
Start date
September 15, 2023
Completion date
August 1, 2033
Enrollment
130 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

arthroplasty, replacement, shoulder, shoulder osteoarthritis